(Q39737606)

English

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Piotr Jan Wysocki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Wiktoria Maria Suchorska

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

object named as

J Malicki

5

0 references

author name string

U Kazimierczak

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Kotlarski

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Mackiewicz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

19 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

465-475

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20168352%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Cytokine-secreting tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Immunotherapeutic potential of whole tumour cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Gp130 and the interleukin-6 family of cytokines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Tribromoethanol (Avertin) as an anaesthetic in mice.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Behavior of murine renal carcinoma cells grown in ectopic or orthotopic sites in syngeneic mice.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Genetically modified dendritic cells--a new, promising cancer treatment strategy?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Human cancer gene therapy with cytokine gene-modified cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Recent developments in renal cell cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

The descent of memory T-cell subsets.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Similarities and differences in CD4+ and CD8+ effector and memory T cell generation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

21 January 2018

IL-6 and GM-CSF in tumor rejection model of renal cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine renal cell carcinoma: evaluation of a dendritic-cell tumour vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25- T Cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39737606&oldid=2203136693"